Janika Viereck
About
In The Last Decade
Janika Viereck
20 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 2.1k
- Cancer Research 2.0k
- Cardiology and Cardiovascular Medicine 393
- Immunology 145
- Surgery 131
Countries citing papers authored by Janika Viereck
This map shows the geographic impact of Janika Viereck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janika Viereck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janika Viereck more than expected).
Fields of papers citing papers by Janika Viereck
This network shows the impact of papers produced by Janika Viereck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janika Viereck. The network helps show where Janika Viereck may publish in the future.
Co-authorship network of co-authors of Janika Viereck
This figure shows the co-authorship network connecting the top 25 collaborators of Janika Viereck. A scholar is included among the top collaborators of Janika Viereck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janika Viereck. Janika Viereck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 27 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 28 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 13 | |
| 10 | Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study breakdown → | 266 |
| 11 | 108 | |
| 12 | 13 | |
| 13 | 270 | |
| 14 | 34 | |
| 15 | 300 | |
| 16 | Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches breakdown → | 1387 |
| 17 | 9 | |
| 18 | 52 | |
| 19 | 19 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.